INC Research Launches Operations in India

INC Research Launches Operations in India

Forms Joint Venture with GVK Biosciences to Offer Full Drug Development Services

INC Research®, a therapeutically focused contract research organization with a trusted process for delivering reliable results, and GVK Biosciences (GVK BIO) today announced that they have entered into a 50:50 equity stake joint venture to form INC GVK BIO Private Limited. The joint venture gives INC Research the capability to run full service, Phase I-IV clinical trials in India for its pharma and biotech customers, utilizing clinical research resources at GVK that are fully dedicated to INC GVK Bio India projects

“This joint venture in India adds significant value to our global service offering, as it combines INC Research’s global drug development experience and therapeutic foresight with the depth of regional expertise and strong clinical research experience of an organization like GVK,” stated Jim Ogle, chief executive officer, INC Research. “This partnership enables both companies to further expand their global reach and supports our growth plan into areas of clinical demand by our customers.”

“Our customers have repeatedly indicated a strong interest in our having a solid operational presence in India. That is why INC Research pursued this targeted expansion of our global geographic footprint,” stated Kelvin Logan, Ph.D., president of INC Research Europe. “While many CROs have simply established in sourcing or off shoring arrangements in India, we chose to develop a more robust solution, developing a joint venture that gives us access to experienced, established teams familiar with the nuances of conducting trials in this part of the world. This joint venture will allow INC Research to further solidify and expand its presence within the world CRO market.”

“The joint venture provides an opportunity for GVK BIO to gain access to INC Research’s global reach while leveraging on its India-based Clinical Research capabilities,” commented G V Sanjay Reddy, chief executive officer, GVK BIO.

About GVK BIO

GVK Biosciences is one of India’s premier contract research organizations, providing an integrated platform of research services across the pharma research & development value chain to a growing number of global pharma and biotech companies. The company combines science, innovation and resources to help clients address their drug discovery and development challenges. Currently the company has more than 1,200 employees spread across facilities in Hyderabad, Chennai and Gurgaon, Delhi. For more information please visit www.gvkbio.com.

About INC Research®

INC Research is a therapeutically focused contract research organization with an unrivaled reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I-Phase IV programs in therapeutic areas of specialty, and in innovative pediatric trials. Our “Trusted Process™” methodology and therapeutic foresight leads our customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, North Carolina, and now in 25 locations in 36 countries worldwide. For more information please visit www.incresearch.com.
Contacts

Townsend Inc. for INC Research
Tanya Orth, 1.858.457.4888, X107
torth {at} townsendinc(.)com
or
GVK Biosciences Private Limited, Hyderabad
Sharada Alvakonda
Senior Manager – Corporate Communications
T +91 40 66619990
F +91 40 66626885
W www.gvkbio.com
M 099892 33415